Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasJustin Z. Wang(University Health Network), Gelareh Zadeh(University Health Network)bioRxiv (Cold Spring Harbor Laboratory)December 10, 202210.1101/2022.12.07.519545Cited by 8SaveCiteExport RISWatch citationsRelated PapersProgrammed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression|Scientific Reports|2020|55Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas|Acta Neuropathologica|2023|48Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities|Nature Communications|2023|44